Porton is excited to announce construction of a new, state-of-the-art Crystallization and Drug Product facility in Cranbury, NJ. The new building is projected to open in Q4 of 2022. This facility will be cGMP capable for Drug Product supplies, and will expand our ability to offer integrated Drug Substance (DS) and Drug Product (DP) R&D […]
New State-of-the-Art Crystallization and Drug Product Facility Read More »
We are very excited to announce the technical program of Pharma Crystallization Summit 2022. This year’s Summit is in-person only and the seats are limited. We cordially invite CMC leaders/managers of drug development programs, API crystallization experts or solution providers, drug formulation experts, and other related professionals to secure your seats by registering early. If
Pharma Crystallization Summit 2022 Technical Program Now Available Read More »
BASKING RIDGE, N.J., June 07, 2022 (GLOBE NEWSWIRE) —Â MetasTx LLCÂ is driven to create novel therapeutics to treat and prevent metastasis of cancers. Harvey Homan, CEO and Co-Founder has successfully presented at Keiretsu Forum Mid-Atlantic and South East, the Annual BioNJ Bio Partnering Conference, AdvanSE Life Science Conference, and several other small venues after closing an
J-Star Research is pleased to announce our collaboration in the 3rd Edition of Fundamentals of Solid Formulation (FSF2022) webinar series, featuring an impressive line-up of speakers and topics. This is a 4-week webinar series with a webinar every Wednesday from April 6 to April 27 organized by XtalPi and J-Star Research, Inc. Each webinar will
3rd Edition of Fundamentals of Solid Formulation (FSF2022) webinar series Read More »
J-Star Research’s subject matter experts are presenting at 2021 AAPS PharmSci360, in Philadelphia, PA, on October 17-20. Our synergistically integrated DS-DP team will discuss the enabling technologies and unique capabilities at J-Star for debottlenecking drug substance (DS) and drug product (DP) developments. We will present through three technical posters and J-Star Booth #1111. Three technical
We are proud to announce that Porton’s Chairman and CEO, Niafeng (Oliver) Ju (EMBA), and San Kiang (Ph.D.), CTO of Porton/J-Star Research, will be Keynote Speaker and CMC Speaker, respectively, at this year’s Sino-American Professionals Association (SAPA) Annual Conference on October 2. Oliver will present “Contract Organizations: from Outsourcing Partner to Infrastructure in the Industry
Porton/J-Star at 2021 SAPA Annual Conference Read More »
Visit J-Star Research and Porton at Booth 2243 from August 10th to 12th at this month’s CPhINorthAmerica event. Our team will be available to discuss your drug development needs. Schedule your meeting in advance: https://calendly.com/jstar-research/30min Please click here for more information on J-Star or here for more information on CPhI North America.
J-Star Research Exhibiting at CPhI North America August 10-12 Read More »
The Center for Pharma Crystallization (CfPC) at J-Star Research, Inc., a US based subsidiary of Porton Pharma Solutions, is pleased to announce the program of the 2nd annual Pharmaceutical Crystallization Summit, to be held on October 14 and 15, 2021, jointly with our partners XtalPi, BlazeMetrics, and Technobis. The 2-day event includes 4 sessions, with
CfPC Announces Program of 2021 Pharmaceutical Crystallization Summit Read More »
On Saturday, June 6, Porton and Tianjin University National Engineering Research Center of Industrial Crystallization Technology (CICT) announced a school-enterprise strategic cooperation to jointly advance CICT’s resource investment, technology development, talent training, teaching, research, industry-university cooperation, and innovation. The first “Porton Industrial Crystallization Scholarship” was awarded to 15 outstanding CICT students at a joint ceremony
Porton awards Industrial Crystallization Scholarship Read More »
May 25, 2002, Shanghai, China. Porton Pharma Solutions Ltd., one of the world’s leading CDMOs, today celebrated the groundbreaking of its new drug product GMP site. Construction of the facility began this month and will continue in phases until the scheduled completion in the third quarter of 2022. Built to exacting FDA/EMA standards, the new site
Porton begins construction on highly anticipated Drug Product GMP site Read More »